ERS International Congress, Milan 2017

Browse by day: Saturday, 09.09.2017 Sunday, 10.09.2017 Monday, 11.09.2017 Tuesday, 12.09.2017 Wednesday, 13.09.2017		Sponsored symposia: Industry Evening Symposium at ERS 2017: “Evolving Concepts in Asthma with Type 2 Inflammation: the Role of Biologics”

Citations should be made in the following way: Authors. Title. Eur Respir J 2017; 50: Suppl. 61, abstract number.

Oral Presentation
Chairs: C. Benden (Zürich, Switzerland), G. Verleden (Leuven, Belgium)

Late Breaking Abstract - Functional Respiratory Imaging (FRI) and machine learning to predict organ rejection shortly after lung transplantation M. Lanclus
Diagnosis of chronic lung allograft dysfunction using absolute values and percentages predicted S. Verleden (Leuven, Belgium)
Post hoc analysis of a randomized trial of azithromycin in bronchiolitis obliterans syndrome after Lung transplantation (BOS); Lung function and survival T. Gan (Groningen, Netherlands)
Pirfenidone in Chronic Lung Allograft Dysfunction after Lung Transplantation: A single-centre experience. A. Fui (La Spezia, SP, Italy)
Relation of sputum and BAL neutrophils to the development of Chronic Lung Allograft Dysfunction after lung transplantation L. Sikkeland (Oslo, Norway)
Gene expression markers to segregate lung transplant rejection phenotypes S. Verleden (Leuven, Belgium)
A role for the mesothelium in restrictive chronic lung allograft dysfunction? A. Sacreas (Leuven, Belgium)
Bioengineered nanoparticles targeted to mesenchymal cells from patients with BOS exert anti-inflammatory activity D. Piloni (PAVIA, Italy)